Coronary artery bypass grafting (CABG) is a common treatment approach for coronary heart disease, which is one of the leading cause of death worldwide. Coronary artery disease occurs when oxygen rich blood flow to the heart muscle gets constricted owing to formation of blocking matter in the wall of coronary arteries and further cause heart attack or chest pain (angina). As per the records of the World Health Organization (WHO), coronary artery disease was responsible for 7.4 million death worldwide in the year 2019 and this global burden of cardiovascular disease is on rise due to sedentary lifestyle and smoking, high blood pressure and cholesterol for inappropriate diet habit, increasing prevalence of diabetes and obesity.

One of the common medical interventions for treating coronary artery disease include coronary artery bypass grafting (CABG). The procedure involves grafting of healthy artery or vein to the blocked part of coronary artery to normalize blood flow to heart. Minimal risk, excellent outcomes and improved long-term survival rates made CABG surgery the most preferred option for coronary artery disease treatment.

Coronary artery bypass grafting market is segmented on the basis of surgery performed: Off pump or beating-heart surgery where grafting is done in beating heart utilizing special equipment, on-pump or arrested-heart surgery where surgery is performed in stopped heart using a heart-lung machine to take over the function of blood circulation and minimally invasive direct coronary artery bypass grafting where small incision is made for bypassing the blood vessel. Depending on the technique followed for CABG procedure, the market is classified as traditional vessel harvesting and endoscopic vessel harvesting (EVH). EVH is set to take over the traditional procedure as a result of its cost effectiveness and successful results. On the basis of device types, the CABG market has been segmented as tissue stabilizers, heart positioners, refractors, cannulas, cardiopulmonary bypass machines, endoscopic vessel harvesting systems and others. The endoscopic vessel harvesting systems segment is on rise on account of their surging demand among surgeons as a result of successful outcomes with minimal complications.

The coronary artery bypass graft market is expected to experience substantial growth as a result of growing prevalence of coronary artery disease. Rising geriatric population fuels the growth of coronary artery bypass graft market by driving the prevalence of chronic diseases like high blood pressure or other cardiovascular disorders. Favorable reimbursement policies for improved medical treatment play an important role to drive the coronary artery bypass graft market. Moreover, the application of other percutaneous coronary interventions (PCI) such as angioplasty and other minimally invasive procedures have been replacing bypass surgery in many cases and hinder the growth of coronary artery bypass grafts market.

The report ‘Coronary Artery Bypass Grafting Devices Market - Growth, Future Prospects, and Competitive Analysis, 2021 – 2029’ provides detailed insights and in-depth analysis of market with prevailing trend to achieve global perspective of coronary artery bypass grafting devices market. This report comprises analysis of market dynamics including market drivers, restrains or market opportunities which allow industry experts to take business strategy. Major competitive landscape analysis of manufacturers with major partnerships, collaboration, mergers and acquisition activities of key players have been delivered in the study. Globally rising health concerns, increasing prevalence of chronic ailments and surging expenditure in research to develop new products boost the growth of coronary artery bypass grafting devices market. This report offers market size and forecast for every stated section with cross-sectional analysis for the duration of 2019-2029 along with corresponding CAGRs for forecast period 2021-2029.

This research report contains brief description of major market players in the field of global coronary artery bypass grafting devices market and the players profiled in this report are Terumo Corporation, Medtronic, MAQUET Holding B.V. & Co.KG, Saphena Medical, Inc., Sorin Group, Vitalitec International, Inc., AtriCure, Inc., Edwards Lifesciences, Genesee Biomedical Inc., KARL STORZ GmbH & Co. KG, Transonic and others.

Tissue stabilizers and heart positioners have a massive role in off pump coronary artery bypass grafts procedure to immobilize the heart. The preference for off pump CABG procedure high owing to clinical advantages, which increases the usage of tissue stabilizers and heart positioners in order to accomplish successful treatment. The market of coronary artery bypass grafts is rising with the increasing usage of endoscopic vessel harvesting systems in bypass grafting procedure. With the recent advancement of technology, scopes of risks and complications have reduced, while using endoscopic vessel harvesting systems in surgeries making these devices more preferred among surgeons. During on pump coronary artery bypass grafting, cardiopulmonary bypass machine is used to take over the function of heart and lung. These devices are currently experiencing huge demand on account of high number of on pump coronary artery bypass grafts procedures in medical facilities. However, its demand is expected to get diminished in coming years due to associated risk and infections

On-pump or traditional coronary artery bypass grafting is the predominant segment where chest is opened to gain access for intervention and heart-lung machine is attached for blood and oxygen flow. More familiarity with this procedure among surgeons makes it the leading segment and preferred procedure. On-pump coronary artery bypass grafts avoids repeat revascularization, which subsequently raised its demand among medical professionals. Increasing number of cardiac emergencies rises the usage of on-pump coronary artery bypass grafting in healthcare facilities.

The market share of off pump bypass grafts is on rise owing to minor chances of risk and infection and avoids morbidity as it is performed without usage of any heart-lung machine. Off-pump bypass grafting shows significant benefits such as shorter recovery time than traditional coronary artery bypass grafting, minimal blood loss, reduced inflammatory response, and lower postoperative complications. Lower morbidity and mortality rate associated to off-pump CABG procedure increases its demand.

Minimally invasive coronary artery bypass grafting is an alternative of traditional coronary bypass artery grafts where small incision is made to gain access to coronary arteries which need to get grafted. The rising demand of this procedure is due to lower risk of infection and complication, minimal scar and increasing patient satisfaction. However, minimally invasive coronary artery bypass grafting is not suitable for multiple diseased vessel and this limitation might hinder the growth of minimally invasive direct coronary artery bypass grafting.

In traditional vessel harvesting, a longer incision is made for removal of vessel to be used for bypass grafting and it leaves extended scar and further wound complications. Traditional vessel harvesting is expected to lose its market share due to increasing demand of endoscopic vessel harvesting (EVH) technique. Endoscopic vessel harvesting is likely to gain considerable acceptance in coming years as a result of minimal complication like infections, scar and hematoma formation, lesser leg wounds and shorter recovery time. In the United States, around 80% coronary artery bypass grafts are performed using EVH technique. In EVH procedure, a smaller incision is made to remove blood vessel using surgical and video equipment. Endoscopic vessel harvesting is anticipated to take over the coronary artery bypass grafting devices market in future due to overall lower medical cost, shorter hospital stay and successful results. The advantage of quick focus on cardiac rehabilitation after bypass grafting, more patient satisfaction and lesser post-operative pain are few driving factors of endoscopic vessel harvesting procedures.

Geographically, the global coronary artery bypass grafting devices market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

North America is estimated to lead the coronary artery bypass grafting devices market with maximum revenue followed by Europe. According to the data of American Heart Association, heart disease is the leading cause of death in the United States where coronary heart disease alone is responsible for killing more than 360,000 people in a year. By the year 2021, the medical cost regarding coronary heart disease was US $ 10.4 Bn which is projected to increase in future years by 100%, and this increasing trend supports the considerable growth of coronary artery bypass grafting devices market in North America. Coronary artery bypass grafting is a commonly performed procedure in the United States with nearly 400,000 procedures per year. The American Heart Association has committed to fund 980 new research projects worth $163 million and this increasing research expenditure is also driving the growth of coronary artery bypass grafting devices market in the United States. Moreover, increasing geriatric population, growing chronic cardiac disorder, rising prevalence of high blood pressure and diabetes are few key factors propelling the growth of coronary artery bypass grafting devices market in this region. As per the record of British Heart Foundation, more than 2.3 million people are suffering from coronary heart diseases in the United Kingdom and this number is on rise due to sedentary lifestyle and smoking habits in Europe region.

Asia Pacific is projected to witness lucrative growth in coming years on account of rising elderly population, increasing prevalence of hypertension, obesity and diabetes which further leads to coronary artery disorders.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Coronary Artery Bypass Grafting Devices (CABG) market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Coronary Artery Bypass Grafting Devices (CABG) market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Coronary Artery Bypass Grafting Devices (CABG) market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Coronary Artery Bypass Grafting Devices (CABG) market?
• Which is the largest regional market for Coronary Artery Bypass Grafting Devices (CABG) market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Coronary Artery Bypass Grafting Devices (CABG) market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Coronary Artery Bypass Grafting Devices (CABG) market worldwide?